Price pressures will remain elevated over the medium term, given structural challenges including an ageing population, geopolitical fragmentation and climate change, said Nagel, who is also a rate ...

He points out, though, that just 5% to 10% of the global population is exposed to cryptocurrency, as he notes some investors remain afraid due to past crises. That's as much of the investment advisory ...

There's a significantly elevated chance that a U.S. recession will begin within the next 12 months. The odds are roughly one in five, in fact, based on the unusually wide spread between the Conference ...

You could say no to your daughter's request and split your estate 50/50 after you're gone. You could give both your son and daughter their inheritance early, leaving yourself perhaps $1 million. Or ...

Goldman Sachs portfolio strategists led by Christian Mueller-Glissmann pinpoint a trio of risks ranging from negative growth surprises, to bond market disturbance at the long end of the curve and a ...

He points out, though, that just 5% to 10% of the global population is exposed to cryptocurrency, as he notes some investors remain afraid due to past crises. That's as much of the investment advisory ...

WPP, in an unscheduled update, now sees comparable revenue falling 3% to 5% for the year, versus February's guidance that it would be flat to down 2%, after a second quarter in which sales slumped as ...

Merck & Co. Inc. is acquiring Verona Pharma PLC in a $10 billion deal that will expand the pharmaceutical giant's portfolio of chronic obstructive pulmonary disease treatments with Verona Pharma's ...

That's because there's no consistent pattern to how the stock market reacts to Fed rate cuts. Sometimes the market will rally in the wake of a cut and sometimes not. Its response is no different than ...

Shares of Vedanta dropped after a report by short seller Viceroy Research took aim at the Indian mining-to-oil conglomerate's parent company. In the report published Wednesday, Viceroy said it is ...

Merck & Co. has struck a roughly $10 billion deal to buy Verona Pharma, bolstering its lineup with the chronic obstructive pulmonary disease treatment Ohtuvayre as it braces for the 2028 loss of ...

TopBuild has struck a deal to buy commercial-roofing services provider Progressive Roofing from alternative asset manager Bow River Capital for $810 million in cash. An internal investigation ...